Skye Bioscience, Inc. (SKYE)

0.7497 +0.02 (+3.12%) USD  |  NASDAQ  |  Dec 31, 16:00
0.7443 -0.01 (-0.72%) After-Hours: 20:00
More

Skye Bioscience Operating Income (Quarterly YoY Growth)

Operating Income (Quarterly YoY Growth) Chart

View Operating Income (Quarterly YoY Growth) for SKYE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Quarterly YoY Growth) Range, Past 5 Years

View Operating Income (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Quarterly YoY Growth) Benchmarks

View Operating Income (Quarterly YoY Growth) Benchmarks
Start Trial
Perspective Therapeutics, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade
FibroGen, Inc. Upgrade
Myomo, Inc. Upgrade